Carl Zeiss Meditec AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE0005313704
EUR
43.30
-80.7 (-65.08%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'16
Jun'16
Mar'16
Dec'15
Sep'15
Jun'15
Mar'15
Net Sales
289.77
257.81
278.18
262.60
291.36
250.74
256.87
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
289.77
257.81
278.18
262.60
291.36
250.74
256.87
Raw Material Cost
132.94
120.19
129.98
125.70
143.49
120.00
123.35
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.68
0.42
0.57
0.49
0.41
0.40
0.36
Selling and Distribution Expenses
79.95
72.82
75.48
73.55
79.16
74.08
72.63
Other Expenses
3.23
2.92
2.91
3.06
2.72
2.78
2.74
Total Expenditure (Excl Depreciation)
245.91
222.62
235.13
230.37
250.26
222.25
223.75
Operating Profit (PBDIT) excl Other Income
43.9
35.2
43.099999999999994
32.2
41.1
28.5
33.1
Other Income
-1.07
-6.12
2.11
-3.60
-8.28
5.48
-13.51
Operating Profit (PBDIT)
48.83
33.87
49.85
33.32
37.31
39.23
24.42
Interest
0.68
0.42
0.57
0.49
0.41
0.40
0.36
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
156.83
137.62
148.20
136.90
147.87
130.74
133.52
Depreciation
6.05
4.80
4.69
4.69
4.49
5.25
4.81
Profit Before Tax
42.10
28.32
44.41
27.94
32.42
33.18
18.97
Tax
11.18
8.61
13.81
8.40
10.83
10.31
5.80
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
30.55
19.78
31.27
16.72
10.00
22.24
11.73
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
30.55
19.78
31.27
16.72
10.00
22.24
11.73
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.37
-0.06
0.98
0.35
0.63
0.29
1.25
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
30.92
19.72
32.25
17.07
10.63
22.53
12.99
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
0.0
0.0
Reserves
797.84
773.32
791.10
775.92
753.86
750.90
719.87
Earnings per share (EPS)
0.38
0.24
0.38
0.21
0.12
0.27
0.14
Diluted Earnings per share
0.38
0.24
0.38
0.21
0.12
0.27
0.14
Operating Profit Margin (Excl OI)
15.13%
13.65%
15.48%
12.27%
14.11%
11.36%
12.89%
Gross Profit Margin
16.62%
12.85%
17.65%
12.43%
12.67%
15.33%
9.26%
PAT Margin
10.54%
7.67%
11.24%
6.37%
3.43%
8.87%
4.57%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2016 is -0.55% vs 23.74% in Sep 2015

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2016 is 191.51% vs -40.45% in Sep 2015

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2016 is 9.43% vs 37.76% in Sep 2015

stock-summary

Interest

YoY Growth in quarter ended Sep 2016 is 75.00% vs 0.00% in Sep 2015

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2016 has improved from Sep 2015

Compare Quarterly Results Of Carl Zeiss Meditec AG With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
289.77
5,581.00
-5,291.23
-94.81%
Other Operating Income
0.00
0.00
0.00
Total Operating income
289.77
5,581.00
-5,291.23
-94.81%
Raw Material Cost
132.94
4,123.00
-3,990.06
-96.78%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.68
86.00
-85.32
-99.21%
Selling and Distribution Expenses
79.95
740.00
-660.05
-89.20%
Other Expenses
3.23
7.80
-4.57
-58.59%
Total Expenditure (Excl Depreciation)
245.91
5,027.00
-4,781.09
-95.11%
Operating Profit (PBDIT) excl Other Income
43.86
554.00
-510.14
-92.08%
Other Income
-1.07
-15.00
13.93
92.87%
Operating Profit (PBDIT)
48.83
807.00
-758.17
-93.95%
Interest
0.68
86.00
-85.32
-99.21%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
156.83
1,458.00
-1,301.17
-89.24%
Depreciation
6.05
268.00
-261.95
-97.74%
Profit Before Tax
42.10
453.00
-410.90
-90.71%
Tax
11.18
146.00
-134.82
-92.34%
Provisions and contingencies
0.00
0
0.00
Profit After Tax
30.55
332.00
-301.45
-90.80%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
30.55
332.00
-301.45
-90.80%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.37
13.00
-12.63
-97.15%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
30.92
345.00
-314.08
-91.04%
Equity Capital
0
0
0.00
Face Value
1.00
1.00
0.00
Reserves
797.84
18,282.00
-17,484.16
-95.64%
Earnings per share (EPS)
0.38
0.59
-0.21
-35.59%
Diluted Earnings per share
0.38
0.59
-0.21
-35.59%
Operating Profit Margin (Excl OI)
15.13%
9.93%
0.00
5.20%
Gross Profit Margin
16.62%
12.92%
0.00
3.70%
PAT Margin
10.54%
5.95%
0.00
4.59%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 28.98 Million
in Sep 2016

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2016 is 12.41% vs -7.33% in Jun 2016

stock-summary

YoY Growth in quarter ended Sep 2016 is -0.55% vs 23.74% in Sep 2015

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.09 Million
in Sep 2016

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2016 is 56.85% vs -39.01% in Jun 2016

stock-summary

YoY Growth in quarter ended Sep 2016 is 191.51% vs -40.45% in Sep 2015

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.99 Million
in Sep 2016

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2016 is 24.75% vs -16.14% in Jun 2016

stock-summary

YoY Growth in quarter ended Sep 2016 is 9.43% vs 37.76% in Sep 2015

Quarterly - Interest
Interest 0.07 Million
in Sep 2016

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2016 is 75.00% vs -33.33% in Jun 2016

stock-summary

YoY Growth in quarter ended Sep 2016 is 75.00% vs 0.00% in Sep 2015

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.13%
in Sep 2016

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2016 has improved from Jun 2016

stock-summary

YoY Growth in quarter ended Sep 2016 has improved from Sep 2015